AUSTIN, Texas--(BUSINESS WIRE)--CDISC announces industry veteran Chris Decker is joining the organization as its new President and Chief Executive Officer effective January 2, 2024, succeeding Dave Evans who will be transitioning into retirement after decades of outstanding service to CDISC.

德克萨斯州奥斯汀——（商业新闻短讯）——CDISC宣布，行业资深人士克里斯·德克（ChrisDecker）将于2024年1月2日加入该组织，担任新总裁兼首席执行官，接替戴夫·埃文斯（DaveEvans），戴夫·埃文斯（DaveEvans）将在为CDISC服务数十年后退休。

Chris is recognized industry wide as a leading technology and standards expert for designing, developing, and implementing complex process and technology solutions. He brings years of experience serving in various executive-level positions across software development, clinical research, and consulting organizations.

Chris是业界公认的设计、开发和实施复杂流程和技术解决方案的领先技术和标准专家。他拥有多年在软件开发、临床研究和咨询组织中担任各种高管职位的经验。

Chris joins CDISC after a fifteen-year tenure at Instem (d-wise) where he was most recently the Vice President, Clinical Solutions defining and implementing the strategy for the company’s clinical products. Over the last 20 years, he has been involved with CDISC as a volunteer, an implementer, and a member of the CDISC Board of Directors focused on driving innovation through standards.

Chris在Instem（d-wise）任职15年后加入CDISC，最近他担任临床解决方案副总裁，负责定义和实施公司临床产品的战略。在过去的20年中，他以志愿者、实施者和CDISC董事会成员的身份参与了CDISC，专注于通过标准推动创新。

He was previously a member of the PHUSE Board of Directors and one of the founding members of the FDA/PHUSE Computational Science collaboration..

他之前是PHUSE董事会成员，也是FDA/PHUSE计算科学合作组织的创始成员之一。。

“Chris’s extensive clinical data expertise and strong industry relationships, combined with his passion for integrating technology and standards are a perfect fit for CDISC. I am excited about Chris taking the helm as the organization continues to move toward technology-based standards future and cultivates deeper relationships with all our stakeholders and partners,” stated Dave Evans, previous CDISC President and CEO..

Dave Evans表示：“Chris拥有丰富的临床数据专业知识和强大的行业关系，再加上他对整合技术和标准的热情，非常适合CDISC。随着公司继续朝着基于技术的标准的未来发展，并与我们所有的利益相关者和合作伙伴建立更深入的关系，我很高兴Chris执掌公司。”，CDISC前任总裁兼首席执行官。。

Current chairperson of the CDISC board of directors Erik Pulkstenis remarked, “We thank Dave for his leadership and vision in guiding CDISC over the past several years. During his tenure, CDISC has continued to expand its impact within the scientific community. We are extremely excited to welcome Chris Decker to the helm of CDISC.

CDISC董事会现任主席埃里克·普尔克斯特尼斯（Erik Pulkstenis）表示：“我们感谢戴夫（Dave）在过去几年中在指导CDISC方面的领导才能和远见。在他的任期内，CDISC继续扩大其在科学界的影响。我们非常高兴地欢迎克里斯·德克（Chris Decker）担任CDISC的掌舵人。

Chris brings a unique combination of entrepreneurial leadership, technical and industry expertise, and personal drive and energy. These will serve the organization well as Chris leads CDISC forward.”.

克里斯将创业领导力、技术和行业专业知识、个人动力和活力独特地结合在一起。这些将很好地服务于组织，因为克里斯领导CDISC前进。”。

In accepting the appointment, CDISC’s new President and CEO said, 'I am excited about the opportunity to lead CDISC in the next phase of their journey to advance clinical research standards. Dave Evans and the CDISC organization have done an exceptional job over the last three years setting the foundation for transformative change.

在接受任命时，CDISC的新任总裁兼首席执行官表示，“我很高兴有机会领导CDISC进入下一阶段，以提高临床研究标准。戴夫·埃文斯（DaveEvans）和CDISC组织在过去三年中做了出色的工作，为变革奠定了基础。

I look forward to working with the exceptional CDISC team and the global user community to move towards expanding the breadth and depth of our work to realize the vision of digital transformation from study design through submission, driving more meaningful clinical research.' Chris received his MS in Statistics from North Carolina State University and his BA in Statistics from Virginia Tech..

我期待着与杰出的CDISC团队和全球用户社区合作，扩大我们工作的广度和深度，实现从研究设计到提交的数字化转型愿景，推动更有意义的临床研究。”克里斯在北卡罗莱纳州立大学获得统计学硕士学位，在弗吉尼亚理工大学获得统计学学士学位。。

ABOUT CDISC

关于CDISC

CDISC creates clarity in clinical research by convening a global community to develop and advance data standards of the highest quality. Required by the United States Food and Drug Administration (FDA) and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA) and adopted by the world’s leading research organizations, CDISC standards enable the accessibility, interoperability, and reusability of data.

CDISC通过召集全球社区开发和推进最高质量的数据标准，为临床研究创造了清晰的思路。CDISC标准由美国食品和药物管理局（FDA）和日本药品和医疗器械管理局（PMDA）要求，由中国国家医疗产品管理局（NMPA）推荐，并被世界领先的研究机构采用，可实现数据的可访问性，互操作性和可重用性。

With the help of CDISC standards, the entire research community can maximize the value of data for more efficient and meaningful research that has invaluable impact on global health. CDISC is a 501(c)(3) global nonprofit charitable organization with administrative offices in Austin, Texas, with hundreds of employees, volunteers, and member organizations around the world..

在CDISC标准的帮助下，整个研究界可以最大限度地提高数据的价值，以进行对全球健康产生宝贵影响的更有效和有意义的研究。CDISC是一家501（c）（3）全球非营利慈善组织，在德克萨斯州奥斯汀设有行政办公室，在世界各地拥有数百名员工、志愿者和成员组织。。